NewsRx Logo Login/Signup
Home Newsletters Products Library About Us Contact -- Search NewsRx

NewsRx | Free Trials
Advertisement
VerticalNews | Global Warming
Advertisement
NewsRx | Free Trials
Advertisement
----------
------------
NewsRx on Facebook
-----
Press Release Submissions
PR Login
*
*

TB & Outbreaks Week

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of TB & Outbreaks Week

Learn More

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Buy Now



Enzyme Research



Investigators at University of Groningen zero in on enzyme research



June 3rd, 2008

According to a study from Netherlands, "The Rhodococcus erythropolis SQ1 kstD3 gene was cloned, heterologously expressed and biochemically characterized as a KSTD3 (3-keto-5 alpha-steroid Delta'-dehydrogenase). Upstream of kstD3, an ORF (open reading frame) with similarity to Delta(4) KSTD (3-keto-5 alpha-steroid Delta(4)-dehydrogenase) was found, tentatively designated kst4D."

"Biochemical analysis revealed that the Delta(1) KSTD3 has a clear preference for 3-ketosteroids with a saturated A-ring, displaying highest activity on 5 alpha-AD (5 alpha-androstane-3,17-dione) and 5 alpha-T (5 alpha-testosterone; also known as 17 beta-hydroxy-5 alpha-androstane-3-one). The...


Source: TB & Outbreaks Week (2008-06-03)

NewsRx Passes
Advertisement
More Articles

Related Topics

------------------------
Security by Verisign PR Login